Skip to main content
Evan Bloch, MD, Pathology, Atherton, CA

Evan Martin Bloch MD

Blood Banking & Transfusion Medicine, Transplantation Immunology, Anatomic Pathology, Clinical Pathology


Assistant Professor of Pathology

Join to view full profile
  • 3351 El Camino RealSte 101Atherton, CA 94027

  • Phone+1 650-306-1016

  • Fax+1 650-369-3627

Dr. Bloch is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Blood Banking/Transfusion Medicine, 2008 - 2009
  • Tufts Medical Center
    Tufts Medical CenterResidency, Pathology-Anatomic and Clinical, 2004 - 2008
  • University of Cape Town Faculty of Medicine
    University of Cape Town Faculty of MedicineClass of 1999

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2015 - 2028
  • CA State Medical License
    CA State Medical License 2007 - 2027
  • Pathology - Anatomic/Pathology - Clinical
    American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • Blood Banking/Transfusion Medicine
    American Board of Pathology Blood Banking/Transfusion Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
  • CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016

Publications & Presentations

PubMed

Journal Articles

  • Risk Factors for Peripartum Blood Transfusion in South Africa: A Case‐Control Study  
    Evan Bloch, MD, Transfusion

Press Mentions

  • Convalescent Plasma Could Be Used as Early Treatment to Keep COVID Patients Out of Hospital
    Convalescent Plasma Could Be Used as Early Treatment to Keep COVID Patients Out of HospitalDecember 21st, 2021
  • Study: Blood Plasma Given Early Reduces Risk for Hospitalization from COVID-19
    Study: Blood Plasma Given Early Reduces Risk for Hospitalization from COVID-19December 21st, 2021
  • Johns Hopkins Receives $35M in Federal Funding for COVID-19 Blood Plasma Trials
    Johns Hopkins Receives $35M in Federal Funding for COVID-19 Blood Plasma TrialsJuly 30th, 2020

Grant Support

  • The Malaria Transfusion Risk (MATRix) StudyJOHNS HOPKINS UNIVERSITY2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: